Bortezomib and donor lymphocyte infusion in multiple myeloma relapsed after allo-SCT does not result in durable remissions

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2011-02, Vol.46 (2), p.319-321
Hauptverfasser:	Hoevenaren, A, van Vulpen, L F D, Levenga, H, Minnema, M C, Raymakers, R
Format:	Artikel
Sprache:	eng
Schlagworte:	631/67/1990/804 692/700/565/545/576/1955 Adult Aged Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Bone marrow Bone marrow, stem cells transplantation. Graft versus host reaction Boronic Acids - therapeutic use Bortezomib Care and treatment Cell Biology Disease-Free Survival Diseases Dosage and administration Female Graft vs Host Disease - etiology Graft vs Tumor Effect Hematology Hematopoietic Stem Cell Transplantation Humans Immunodeficiencies. Immunoglobulinopathies Immunoglobulinopathies Immunopathology Internal Medicine letter-to-the-editor Lymphocyte Transfusion Lymphocytes Male Medical sciences Medicine Medicine & Public Health Middle Aged Multiple myeloma Multiple Myeloma - mortality Multiple Myeloma - therapy Physiological aspects Public Health Pyrazines - therapeutic use Recurrence Relapse Retrospective Studies Stem cell transplantation Stem Cells Tissue Donors Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplantation Transplantation, Homologous
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!